Pharsight

Prestalia patents expiration

PRESTALIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6696481 ADHERA Salt of perindopril and pharmaceutical compositions containing it
Apr, 2023

(1 year, 1 month ago)

US7846961 ADHERA α crystalline form of the arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
Oct, 2029

(5 years from now)

Prestalia is owned by Adhera.

Prestalia contains Amlodipine Besylate; Perindopril Arginine.

Prestalia has a total of 2 drug patents out of which 1 drug patent has expired.

Expired drug patents of Prestalia are:

  • US6696481

Prestalia was authorised for market use on 21 January, 2015.

Prestalia is available in tablet;oral dosage forms.

Prestalia can be used as treatment of hypertension.

The generics of Prestalia are possible to be released after 05 October, 2029.

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jan 21, 2018

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using AMLODIPINE BESYLATE; PERINDOPRIL ARGININE ingredient

Market Authorisation Date: 21 January, 2015

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

How can I launch a generic of PRESTALIA before it's drug patent expiration?
More Information on Dosage

PRESTALIA family patents

Family Patents